Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.

Heart Protection Study Collaborative Group (2005) Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals. Lancet, 365 (9473). pp. 1779-1780. ISSN 1474-547X

Full text not available from this repository.
Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: EPrints Services
Date Deposited: 25 Nov 2010 11:13
Last Modified: 03 Oct 2022 02:51
URI: https://ueaeprints.uea.ac.uk/id/eprint/15416
DOI: 10.1016/S0140-6736(05)63014-0

Actions (login required)

View Item View Item